Overview

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
As studies demonstrate, the administration of recombinant human GH (rhGH) in adults with GH deficiency has been known to improve metabolic impairment and quality of life. Patients, however, do have to tolerate daily injections of GH (rhGH).
Phase:
Phase 4
Details
Lead Sponsor:
LG Life Sciences